- Report
- August 2023
- 17 Pages
France
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
China
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Brazil
From €2858EUR$2,995USD£2,395GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- November 2021
- 844 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- October 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- April 2023
- 250 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- February 2023
- 220 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- March 2022
- 220 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Book
- August 2013
- 248 Pages
- Book
- August 2021
Global
- Book
- April 2019
North America
- Book
- September 2018
North America

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more